The FDA encourages sponsors to discuss plans to use animal testing alternatives, called new approach methodologies or NAMs, ...
Pharmaceutical Technology on MSN
FDA steps back from preclinical primate testing amid wider regulatory shift
New non-primate draft guidance follows the agency’s wider aim to curtail the use of animal testing in preclinical toxicology.
Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating therapies for patients. NEW HAVEN, CT / ACCESS Newswire / December 5, 2025 / ...
The draft guidance issued Tuesday comes as regulators and policymakers have looked for ways to aid U.S. drugmakers amid fast progress by their China-based counterparts.
For certain monospecific antibodies, three-month toxicology studies plus other supportive evidence will suffice, eliminating ...
On , The US Food and Drug Administration issued draft guidance identifying specific types of monoclonal antibody products for which the agency believes six-month toxicity testing in non-human primates ...
AZ Animals on MSN
The CDC is ending testing on monkeys. Here’s what we know.
For decades, animals have been used in scientific and medical research. Naturally, some supported research on animals, while ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
Despite movements to end testing, cosmetic, pharmaceutical, and other companies continue to test on hundreds of millions of ...
More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback